Effects of binding of ligand (FVIIa) to induced tissue factor in human endothelial cells

Thrombosis Research

Volumn 98, Issue 4, 2000, Pages 311-321

  Wiiger, Merete T ^a   Pringle, Serena ^a   Pettersen, Kjell Sverre ^a   Narahara, Nobuhiro ^a,b   Prydz, Hans ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Endothelial cells; FVII; Tissue factor; Tissue factor pathway inhibitor; von Willebrand factor

Indexed keywords

PLASMINOGEN ACTIVATOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANNEXIN A5; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FACTOR VIIA; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; INTERLEUKIN-1; LIGANDS; LIPOPROTEINS; LIPOSOMES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY PROTEINS; PROTEIN BINDING; RNA, MESSENGER; STIMULATION, CHEMICAL; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 0034657011     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00183-3     Document Type: Article

References (36)

1. Spicer E.K., Horton R., Bloem L., Bach R., Williams K.R., Guha A., Kraus J., Lin T.C., Nemerson Y., Koningsberg W.H. Isolation of cDNA clones coding for human tissue factor; primary structure of the protein and cDNA. Proc Natl Acad Sci USA. 84:1987;5148-5152.
2. Scarpati E.M., Wen D., Broze G.J., Miletich J.P., Flandermeyer R.R. Human tissue factor. cDNA sequence and chromosome localization of the gene Biochemistry. 26:1987;5234-5238.
3. Fisher K., Gorman C.M., Vehar G.A., O'Brien D.P., Lawn R.M. Cloning and expression of human tissue factor cDNA. Thromb Res. 48:1987;89-99.
4. Morrissey J.H., Fakhari H., Edgington T.S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell. 50:1987;129-135.
5. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA. 87:1990;6934-6938.
6. Edgington T.S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemostas. 66:1991;67-77.
7. Ho A.S.Y., Liu V., Khan T.A., Hsu D.H., Bazan J.F., Moore K.W. A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci USA. 90:1993;11267-11271.
8. Lutfalla G., McInnis M.G., Antonarakis S.E., Uze G. Structure of the human CRFB4 gene. Comparison with its IFNAR neighbour J Mol Evol. 41:1995;338-344.
9. Harlos K., Martin D.M.A., O'Brien D.P., Jones E.Y., Stuart D.I., Poliarpov I., Miller A., Tuddenham E.G.D., Boys C.W.G. Crystal structure of the extracellular region of human tissue factor. Nature. 370:1994;662-666.
10. 2+ signals in J82 cells, transfected COS-1 cells, MDCK cells and in human endothelial cells induced to synthesise tissue factor. J Biol Chem. 270:1995;4650-4660.
11. Camerer E., Røttingen J.A., Iversen J.-G., Prydz H. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Derby canine kidney cells only when proteolytically active. J Biol Chem. 271:1996;29034-29042.
12. Jaffe E.A., Nachmann R.I., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 52:1973;2745-2756.
13. Narahara N., Enden T., Wiiger M., Prydz H. Polar expression of tissue factor in human umbilical cord vein endothelial cells. Arterioscl Thromb. 14:1994;1815-1820.
14. Hvattum M., Prydz H. Studies on tissue thromboplastin. Biochim Biophys Acta. 130:1966;92-101.
15. Hjort P.F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand J Clin Invest. 9(Suppl. 27):1957;1-183.
16. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 87:1978;206-210.
17. Camerer E., Pringle S., Skartlien A.H., Wiiger M., Prydz K., Kolstø A.B., Prydz H. Opposite sorting of tissue factor in human umbilical vein endothelial cells and Madin-Darby canine kidney epithelial cells. Blood. 88:1996;1339-1349.
18. Sandset P.M., Abildgaard U., Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res. 47:1987;389-400.
19. Lyberg T, Galdal KS, Prydz H. Synthesis of thromboplastin protein in endothelial cells. In: 2nd International Symposium on the Biology of the Vascular Endothelial Cell. Cambridge, UK: University Press; 1981. p. 107.
20. Andoh K., Pettersen K.S., Filion-Myklebust C., Prydz H. Observations on the cell biology of tissue factor in endothelial cells. Thromb Haemostas. 63:1990;298-302.
21. Lupu C., Lupu F., Dennehy U., Kakkar V.V., Scully M.F. Thrombin induces the redistribution and acute release of tissue factor inhibitor from specific granules within human endothelial cells in culture. Arterioscl Thromb Vasc Biol. 15:1995;2055-2062.
22. Walsh J.D., Geczy C.L. Discordant expression of tissue factor antigen and procoagulant activity on human monocytes activated with LIPOPOLYSACCARIDE and low dose cycloheximide. Thromb Haemostas. 66:1991;552-558.
23. Scarpati E.M., Sadler J.E. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem. 264:1989;20705-20713.
24. Crossman D.C., Carr D.P., Tuddenham E.G.D., Pearson J.D., McVey J.H.C. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 265:1990;9782-9787.
25. Bjørklid E., Storm E. Purification and some properties of the protein component of tissue thromboplastin. Biochemical J. 165:1977;89-96.
26. Le D.T., Rapaport S.I., Rao V.M. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem. 267:1992;15447-15454.
27. Le D.T., Rapaport S.I., Rao V.M. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide. Thromb Haemostas. 72:1994;848-855.
28. Simionescu N., Simionescu M., Palade G.E. Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites. J Cell Biol. 90:1981;605-613.
29. Sevinsky J.R., Rao L.V.M., Ruf W. Ligand induced protease receptor translocation into caveolae. A mechanism for regulating cell surface proteolysis of the tissue factor dependent coagulation pathway J Cell Biol. 133:1996;293-304.
30. Mulder A.B., Smit J.W., Bom V.J.J., Blom N.L., Ruiters M.H.J., Halie M.R., van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood. 88:1996;1306-1313.
31. Broze G.J. Jr., Warren L.A., Novotny W.F., Higuchi D.A., Girard J.J., Miletich J.P. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa. Insight into its possible mechanism of action Blood. 71:1988;335-343.
32. Warn-Cramer B.J., Rao L.V., Maki S.L., Rapaport S.I. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor. Evidence for a two-step model of inhibition Thromb Haemost. 60:1988;453-456.
33. Girard T.J., Warren L.A., Novotny W.F., Likert K.M., Brown S.G., Miletich J.P., Broze G.J. Jr. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 338:1989;518-520.
34. Broze G.J. Jr., Girard T.J., Novotny W.F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 29:1990;7539-7546.
35. Callander N.S., Rao L.V., Nordfang O., Sandset P.M., Warn-Cramer B., Rapaport S.I. Mechanisms for binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem. 267:1992;876-882.
36. Hamik A., Setiadi H., Bu G., McEver R.P., Morrissey J.H. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. J Biol Chem. 274:1999;4962-4969.